# Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia

> **NCT04533724** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 6 (estimated)

## Conditions studied

- Negative Symptom
- Schizophrenia
- Amisulpride
- Gut Microbiomes

## Interventions

- **DRUG:** Amisulpride

## Key facts

- **NCT ID:** NCT04533724
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-30
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2020-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04533724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04533724, "Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04533724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*